A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
Public ClinicalTrials.gov record NCT02407054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blinded, Placebo-Controlled, Randomized Phase II Study of Enzalutamide With or Without the PI3 Kinase/mTOR Inhibitor LY3023414 in Men With Metastatic Castration Resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.
Study identification
- NCT ID
- NCT02407054
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 142 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2015
- Primary completion
- Sep 25, 2018
- Completion
- Apr 15, 2020
- Last update posted
- May 10, 2021
2015 – 2020
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urology Centers of Alabama, P.C. | Homewood | Alabama | 35209 | — |
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | — |
| Prostate Oncology Specialists | Marina del Rey | California | 90292 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Florida Cancer Specialists | Fort Myers | Florida | 33901 | — |
| Florida Cancer Specialists North | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists East | West Palm Beach | Florida | 33401 | — |
| Ingalls Memorial Hospital | Harvey | Illinois | 60426 | — |
| Fort Wayne Oncology & Hematology | Fort Wayne | Indiana | 46845 | — |
| Indiana Cancer Pavilion | Indianapolis | Indiana | 46202-5286 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Minnesota Oncology/Hematology PA | Minneapolis | Minnesota | 55404 | — |
| Urology Cancer Center | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89148 | — |
| Garden State Urology | Morristown | New Jersey | 07960 | — |
| Delaware Valley Urology | Voorhees Township | New Jersey | 08043 | — |
| Associated Medical Professionals of NY | Syracuse | New York | 13210 | — |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Oregon Urology Institute | Springfield | Oregon | 97477 | — |
| Northwest Cancer Specialists PC | Tualatin | Oregon | 97062 | — |
| Urological Associates of Lancaster | Lancaster | Pennsylvania | 17604 | — |
| Univ of Pittsburgh Cancer Inst. (UPCI) | Pittsburgh | Pennsylvania | 15213 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Sarah Cannon Research Institute SCRI | Nashville | Tennessee | 37203 | — |
| Tennessee Oncology PLLC | Nashville | Tennessee | 37203 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Southwestern Medical Center - Dallas | Dallas | Texas | 75390 | — |
| Texas Oncology-Baylor Charles A. Sammons Cancer Center | Fort Worth | Texas | 76104 | — |
| Texas Oncology-Memorial City | Houston | Texas | 77024 | — |
| US Oncology | The Woodlands | Texas | 77380 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22903 | — |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Swedish Medical Center | Seattle | Washington | 98104 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02407054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 10, 2021 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02407054 live on ClinicalTrials.gov.